Buklizin
Buklizin je antihistaminik i antiholinergik iz familije piperazinskih derivata.[5] On se smatra antiemetikom, slično meklozinu.
(IUPAC) ime | |||
---|---|---|---|
(RS)-1-[(4-hlorofenil)- fenil-metil]-4- [(4-tert-butilfenil) metil] piperazin | |||
Klinički podaci | |||
AHFS/Drugs.com | Mikromedeks, detaljne potrošačke informacije | ||
Identifikatori | |||
CAS broj | 82-95-1 | ||
ATC kod | R06AE01 | ||
PubChem[1][2] | 6729 | ||
DrugBank | DB00354 | ||
ChemSpider[3] | 6473 | ||
UNII | 0C94V6X681 | ||
ChEBI | CHEBI:3205 | ||
ChEMBL[4] | CHEMBL1201271 | ||
Hemijski podaci | |||
Formula | C28H33ClN2 | ||
Mol. masa | 433,028 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status |
U Ujedinjenom Kraljevstvu, buklizin je jedan od tri leka koji sadržanih u Migralev tabletama[6], koje se koriste za tretiranje migrene.
Reference uredi
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.
- ↑ Gaillard GE. (1955). „Clinical evaluation of a new antihistamine, buclizine hydrochloride (vibazine)”. J Allergy. 26: 373-6.
- ↑ Migraleve[mrtav link]